Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Saved in:
Bibliographic Details
Title: Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
Authors: Aiko, Naoto1 na1435john@gmail.com, Shimokawa, Tsuneo1 ts00-shimokawa@city.yokohama.jp, Miyazaki, Kazuhito1 ka05-miyazaki@city.yokohama.jp, Misumi, Yuki1 yu02-misumi@city.yokohama.jp, Agemi, Yoko1 yo01-agemi@city.yokohama.jp, Ishii, Mari2 ma37-ishii@city.yokohama.jp, Nakamura, Yukiko1 yu43-nakamura@city.yokohama.jp, Yamanaka, Takeharu3 takeharu.yamanaka@gmail.com, Okamoto, Hiroaki1 hi01-okamoto@city.yokohama.jp
Source: BMC Cancer. 10/22/2018, Vol. 18 Issue 1, p1-7. 7p. 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-018-4911-7